Biotechnology News and Research

RSS

Complex network of molecules controls formation and activity of neuronal connections

Environment moulds behaviour - and not just that of people in society, but also at the microscopic level. This is because, for their function, neurons are dependent on the cell environment, the so-termed extracellular matrix.

7 May 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Kinase inhibitors are molecules that block the activity of kinases. Kinases are a specific class of enzymes. They are extremely important in signal transduction processes in the human body meaning that they actually regulate most of the physiological processes that take place in the body.

7 May 2013

Study offers new hope to patients suffering from laminopathies

Laminopathies are hereditary diseases that affect mainly the muscle tissue. These diseases include for example Emery-Dreifuss Muscular dystrophy, dilated cardiomyopathy, limb-girdle muscular dystrophy and Hutchison-Gilford progeria syndrome.

7 May 2013

Biocryst reports financial results for first quarter 2013

BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2013.

7 May 2013

FARMARABA and Neiker-Tecnalia use marine plant micro-organisms to produce Omega 3

Neiker-Tecnalia, the Basque Institute for Agricultural Research and Development, and the company FARMARABA S.L. are working together on a Project designed to produce Omega 3 using marine plant micro-organisms. The ultimate aim is to develop in-house technologies to obtain this highly valued fatty acid, and then apply them at a FARMARABA production plant.

7 May 2013

Royal Society elects scientists from JIC for advances in antibiotic discovery and in crop improvement

Two scientists from the John Innes Centre have been elected as Fellows of the Royal Society, the premier scientific accolade in the UK. Their breakthroughs in fundamental research have pioneered advances in antibiotic discovery and in crop improvement from which we all benefit.

6 May 2013

Scientists develop NMR spectrometer for data analysis

In a world first, scientists from the Institute of Food Research (IFR) on the Norwich Research Park have been test-driving a prototype instrument that promises to revolutionise access to a potent laboratory analysis technique called NMR (Nuclear Magnetic Resonance).

6 May 2013

NeuroPhage Pharmaceuticals raises $6.4 million in private equity financing round

NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round.

6 May 2013

Novel screening method for identifying inhibitors of EZH2 methyltransferase

Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. Understanding and being able to control these alterations could lead to new approaches for activating or inactivating genes linked to cancer.

5 May 2013

Study reveals how the properties of embryonic stem cells are controlled

Scientists have made a fundamental discovery about how the properties of embryonic stem cells are controlled.

3 May 2013

Tosoh Bioscience announces GPC glossary and column selection mobile app

Tosoh Bioscience LLC has announced the availability of the GPC Glossary and Column Selection Guide app, which offers easy access to 200 Gel Permeation Chromatography (GPC) terms and a GPC column selection wizard for precise directions to the ideal GPC columns for polymer molar mass distribution characterization.

2 May 2013

Polymers for pulmonary drug delivery book released by Smithers Rapra

Pulmonary drug delivery has been a rapidly expanding field, moving from the traditional propellant based metered dose inhaler delivery of small asthma drugs, to a broader landscape of new devices and novel drugs for local and systemic delivery.

30 Apr 2013

Glide Pharma awarded contract from Pfenex Inc. to develop a solid formulation of recombinant anthrax vaccine

Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.

30 Apr 2013

Researchers say tiny thymus teaches immune system to ignore foreign bacteria in gut

The tiny thymus teaches the immune system to ignore the teeming, foreign bacteria in the gut that helps you digest and absorb food, researchers say.

30 Apr 2013

Maruishi gains exclusive rights to develop, commercialize Cara Therapeutics' CR845 in Japan

Cara Therapeutics, Inc. and Maruishi Pharmaceutical Company, Ltd. today announced that they have entered into a License Agreement providing Maruishi with exclusive rights to develop, manufacture and commercialize Cara's lead analgesic drug candidate, CR845, for acute pain and uremic pruritus in Japan.

29 Apr 2013

Averica Discovery Services establishes research collaboration with Worcester Polytechnic Institute

Averica Discovery Services, a contract research organization with specialized expertise in small molecule analysis and purification, today announced that it has established a research collaboration with the Department of Chemistry and Biochemistry at Worcester Polytechnic Institute.

29 Apr 2013

Oramed to report results of T1DM oral insulin formulation at Diabetes Summit 2013

Oramed Pharmaceuticals Inc., a developer of oral delivery systems of drugs currently administered by injection, announced today that its abstract, entitled "Oral insulin capsules toward management of Type 1 diabetes mellitus," will be presented at the Global Technology Community Diabetes Summit 2013.

29 Apr 2013

Opsona raises €33M in oversubscribed financing round

Opsona Therapeutics Limited, the innate immune drug development company, today announced that it has raised €33 million (US $ 43 million) in an oversubscribed Series C financing.

29 Apr 2013

Oxford BioTherapeutics, Boehringer Ingelheim team up to discover novel cancer antibody targets

Oxford BioTherapeutics and Boehringer Ingelheim today announce a new alliance focused on the discovery of novel cancer antibody targets that OBT will identify with the help of its OGAP® discovery platform.

29 Apr 2013

ACT announces European phase I clinical trial for Stargardt's disease using retinal pigment epithelial cells

Advanced Cell Technology, Inc. a leader in the field of regenerative medicine, today announced treatment of the first patient in the third dosage cohort, and seventh patient overall, in its European Phase I clinical trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

26 Apr 2013

Biotechnology News and Research

Complex network of molecules controls formation and activity of neuronal connections

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Study offers new hope to patients suffering from laminopathies

Biocryst reports financial results for first quarter 2013

FARMARABA and Neiker-Tecnalia use marine plant micro-organisms to produce Omega 3

Royal Society elects scientists from JIC for advances in antibiotic discovery and in crop improvement

Scientists develop NMR spectrometer for data analysis

NeuroPhage Pharmaceuticals raises $6.4 million in private equity financing round

Novel screening method for identifying inhibitors of EZH2 methyltransferase

Study reveals how the properties of embryonic stem cells are controlled

Tosoh Bioscience announces GPC glossary and column selection mobile app

Polymers for pulmonary drug delivery book released by Smithers Rapra

Glide Pharma awarded contract from Pfenex Inc. to develop a solid formulation of recombinant anthrax vaccine

Researchers say tiny thymus teaches immune system to ignore foreign bacteria in gut

Maruishi gains exclusive rights to develop, commercialize Cara Therapeutics' CR845 in Japan

Averica Discovery Services establishes research collaboration with Worcester Polytechnic Institute

Oramed to report results of T1DM oral insulin formulation at Diabetes Summit 2013

Opsona raises €33M in oversubscribed financing round

Oxford BioTherapeutics, Boehringer Ingelheim team up to discover novel cancer antibody targets

ACT announces European phase I clinical trial for Stargardt's disease using retinal pigment epithelial cells

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News